-
Recent Posts
- Uniting to combat neglected tropical diseases: public-private partnership
- International treaty signed to combat growing counterfeit drug industry
- GSK malaria vaccine could save millions of lives
- Global pharmaceutical industry contributes action plan and research to fighting NCDs in the developing world
- The fight against TB: Bayer donates drugs to WHO program
Archives
- January 2012
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
Leave a Reply Cancel reply
Twitter
- RT @LillyPad: Any given day, 40k websites peddle Rx drugs, but 95% of sites are illegitimate/fake. fighting #fakemeds ow.ly/biAlc 2 days ago
- RT @LillyPadCA: Ameliorer la propriete intellectuel va aider le Canada a se maintenir avec ses concurrents globaux. Venez en apprendre... 3 days ago
- #WHA65 delegates approved draft resolution on a mechanism proposing intl cooperation on counterfeit medical products bit.ly/KWtlBN 6 days ago
- RT @Med_Innovation: Study by @uschamber finds intellectual property industries produce $5 trillion of America's GDP bit.ly/JIA1sh ... 6 days ago
- RT @WHO: The resolution on medical products reiterates that @WHO continue to strengthen national regulatory authorities, financing. #WHA65 1 week ago
Tags
access to medicines Africa AIDS Asia asthma Bill & Melinda Gates Foundation Canada China chronic conditions compulsory licencing Counterfeit drugs counterfeit medicines drug development drug pricing drug resistance economic development Europe GAVI Alliance global health H1N1 IGWG immunization India Innovation intellectual property internet pharmacies Latin America least-developed countries malaria Millenium Development Goals neglected diseases patents patients patient safety polio Public health research-based pharmaceutical industry Swine flu tuberculosis United Nations United States of America vaccine World Health Assembly World Health Organization World Intellectual Property Association1356
Resources
Site Meter
Blog at WordPress.com. Theme: Digg 3 Column by WP Designer.
IFPMA launches NCD Framework for Action
IFPMA (International Federation of Pharmaceutical Manufacturers & Associations) recently released a NCD Framework for Action, highlighting specific areas of action including: innovation, access and affordability, prevention and health education. The document underscores the essential role of partnerships in addressing the challenge of non-communicable disease.
Read more about the NCD Framework for Action:
PharmaTimes – IFPMA pledges action on non-communicable diseases
IFPMA – Research-based pharmaceutical industry launches collaborative framework to tackle NCDs
Share this:
Filed under: Commentary on news & events, Public health Tagged: | chronic conditions, global health, NCDs